Literature DB >> 24175232

Viral manipulation of cellular protein conjugation pathways: The SUMO lesson.

Domenico Mattoscio1, Chiara V Segré, Susanna Chiocca.   

Abstract

Small ubiquitin-like modifier (SUMO)ylation is a key post-translational modification mechanism that controls the function of a plethora of proteins and biological processes. Given its central regulatory role, it is not surprising that it is widely exploited by viruses. A number of viral proteins are known to modify and/or be modified by the SUMOylation system to exert their function, to create a cellular environment more favorable for virus survival and propagation, and to prevent host antiviral responses. Since the SUMO pathway is a multi-step cascade, viral proteins engage with it at many levels, to advance and favor each stage of a typical infection cycle: replication, viral assembly and immune evasion. Here we review the current knowledge on the interplay between the host SUMO system and viral lifecycle.

Entities:  

Keywords:  Exploitation; Immune evasion; Innate immunity; Small ubiquitin-like modifier; Small ubiquitin-like modifier-ylation; Virus; Virus assembly

Year:  2013        PMID: 24175232      PMCID: PMC3785051          DOI: 10.5501/wjv.v2.i2.79

Source DB:  PubMed          Journal:  World J Virol        ISSN: 2220-3249


  122 in total

1.  TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation.

Authors:  Yutaka Morita; Chie Kanei-Ishii; Teruaki Nomura; Shunsuke Ishii
Journal:  Mol Biol Cell       Date:  2005-09-14       Impact factor: 4.138

2.  Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever.

Authors:  Mike Bray; Thomas W Geisbert
Journal:  Int J Biochem Cell Biol       Date:  2005-03-07       Impact factor: 5.085

Review 3.  Something about SUMO inhibits transcription.

Authors:  Grace Gill
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

4.  Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification.

Authors:  Yoshihiro Izumiya; Thomas J Ellison; Edward T H Yeh; Jae U Jung; Paul A Luciw; Hsing-Jien Kung
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex.

Authors:  L Gong; B Li; S Millas; E T Yeh
Journal:  FEBS Lett       Date:  1999-04-01       Impact factor: 4.124

6.  Influenza A virus interacts extensively with the cellular SUMOylation system during infection.

Authors:  Sangita Pal; Andres Santos; Juan M Rosas; Joshua Ortiz-Guzman; Germán Rosas-Acosta
Journal:  Virus Res       Date:  2011-03-03       Impact factor: 3.303

7.  Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.

Authors:  Andrew Yueh; Juliana Leung; Subarna Bhattacharyya; Lucy A Perrone; Kenia de los Santos; Szy-Yuan Pu; Stephen P Goff
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.

Authors:  Stefan Weger; Eva Hammer; Regine Heilbronn
Journal:  FEBS Lett       Date:  2005-09-12       Impact factor: 4.124

9.  Genetic Studies of the beta-hairpin loop of Rous sarcoma virus capsid protein.

Authors:  Jared L Spidel; Carol B Wilson; Rebecca C Craven; John W Wills
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific.

Authors:  Pei-Ching Chang; Yoshihiro Izumiya; Chun-Yi Wu; Latricia D Fitzgerald; Mel Campbell; Thomas J Ellison; Kit S Lam; Paul A Luciw; Hsing-Jien Kung
Journal:  J Biol Chem       Date:  2009-12-24       Impact factor: 5.157

View more
  18 in total

1.  Reprogramming the host: Modification of cell functions upon viral infection.

Authors:  Gualtiero Alvisi; Giorgio Palù
Journal:  World J Virol       Date:  2013-05-12

2.  SUMO Modification Stabilizes Enterovirus 71 Polymerase 3D To Facilitate Viral Replication.

Authors:  Yan Liu; Zhenhua Zheng; Bo Shu; Jin Meng; Yuan Zhang; Caishang Zheng; Xianliang Ke; Peng Gong; Qinxue Hu; Hanzhong Wang
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

3.  In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.

Authors:  Wan-Shan Yang; Mel Campbell; Hsing-Jien Kung; Pei-Ching Chang
Journal:  J Vis Exp       Date:  2018-01-29       Impact factor: 1.355

4.  Proteomic profiling identifies the SIM-associated complex of KSHV-encoded LANA.

Authors:  Jin Gan; Chong Wang; Yanling Jin; Yi Guo; Feng Xu; Qing Zhu; Ling Ding; Hong Shang; Junwen Wang; Fang Wei; Qiliang Cai; Erle S Robertson
Journal:  Proteomics       Date:  2015-05-26       Impact factor: 3.984

5.  Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.

Authors:  Jennifer M Higginbotham; Clodagh C O'Shea
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

6.  The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections.

Authors:  Domenico Mattoscio; Chiara Casadio; Marzia Fumagalli; Mario Sideri; Susanna Chiocca
Journal:  Ecancermedicalscience       Date:  2015-04-29

7.  K-bZIP Mediated SUMO-2/3 Specific Modification on the KSHV Genome Negatively Regulates Lytic Gene Expression and Viral Reactivation.

Authors:  Wan-Shan Yang; Hung-Wei Hsu; Mel Campbell; Chia-Yang Cheng; Pei-Ching Chang
Journal:  PLoS Pathog       Date:  2015-07-21       Impact factor: 6.823

Review 8.  SUMO and KSHV Replication.

Authors:  Pei-Ching Chang; Hsing-Jien Kung
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

9.  Computational discovery of Epstein-Barr virus targeted human genes and signalling pathways.

Authors:  Suyu Mei; Kun Zhang
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

10.  Regulated transport into the nucleus of herpesviridae DNA replication core proteins.

Authors:  Alvisi Gualtiero; David A Jans; Daria Camozzi; Simone Avanzi; Arianna Loregian; Alessandro Ripalti; Giorgio Palù
Journal:  Viruses       Date:  2013-09-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.